ITeos Therapeutics Inc
|Market Cap (Intraday)||964.43M|
|2yr Forward PE||N/A|
ITeos Therapeutics Inc Stock, NASDAQ:ITOS
iTeos Therapeutics, Inc. engages in the development of biopharmaceuticals therapeutic products and services. It offers immuno-oncology therapeutics for patients. The company was founded by Michel Detheux in April 2012 and is headquartered in Cambridge, MA.